arrow
B

Ben J. Harrison

University of Melbourne
H指数:76
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group

区域性脑部形态结构与当前抗抑郁药使用:ENIGMA重度抑郁症工作组32个国际队列的研究结果

2025-11-030
OAAI
Classification of major depressive disorder using vertex-wise brain sulcal depth, curvature, and thickness with a deep and a shallow learning model

使用深度学习和浅层学习模型,基于顶点级脑沟深度、曲率和厚度的重度抑郁症分类

2025-10-030
OA
Neural correlates of human fear conditioning and sources of variability in 2199 individuals

人类恐惧条件反射的神经相关物及2199名个体中的变异来源

2025-08-230
OAAI
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy

二线化疗进展后的转移性三阴性乳腺癌患者中Imprime与Pembrolizumab免疫疗法的二期临床试验

2025-05-080
PRE
Habenula contributions to negative self-cognitions

下丘脑对负面自我认知的贡献

2025-05-070
OAAI
Predicting Antidepressant Treatment Response From Cortical Structure on MRI: A Mega-Analysis From the ENIGMA-MDD Working Group
2025-01-060
OAAI
Brain-age prediction: Systematic evaluation of site effects, and sample age range and size

脑年龄预测: 对部位影响以及样本年龄范围和大小的系统评估

2024-07-015
OAAI
HC-7366, a potent GCN2 activator, complements belzutifan, a HIF-2α antagonist, by providing combination benefit in belzutifan-sensitive models and monotherapy activity in belzutifan-resistant models
2024-03-220
PRE
Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures

使用机器学习对皮质和皮质下测量的重性抑郁症进行多站点基准分类

2024-01-115
OAAI